Filovirus vaccines
- PMID: 21519188
- PMCID: PMC3219077
- DOI: 10.4161/hv.7.6.15398
Filovirus vaccines
Abstract
Filoviruses can cause severe and often fatal hemorrhagic fever in humans and non-human primates (NHPs). Although there are currently no clinically proven treatments for filovirus disease, much progress has been made in recent years in the discovery of therapeutics and vaccines against these viruses. A variety of vaccine platforms have been shown to be effective against filovirus infection. This review summarizes the literature in this field, focusing on vaccines that have been shown to protect NHPs from infection. Furthermore, the uses of rodent models in vaccine development, as well as correlates of immunity, are discussed.
References
-
- Kuhn JH. Filoviruses. A compendium of 40 years of epidemiological, clinical and laboratory studies. Arch Virol. 2008;20:13–360. - PubMed
-
- Warfield KL, Deal EM, Bavari S. Filovirus infections. J Am Vet Med Assoc. 2009;234:1130–1139. - PubMed
-
- Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet. 1995;346:1669–1671. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources